TSLA Quantitative Stock Analysis

Validea's guru fundamental report on Tesla (TSLA) assigns a 68% rating using the Motley Fool Small-Cap Growth Investor model, despite TSLA being a large-cap stock. While the company passed several fundamental checks including profit margin, cash flow from operations, and long-term debt/equity, it failed key growth-oriented criteria such as relative strength, year-over-year sales and EPS growth, and the 'Fool Ratio' (P/E to growth). This 68% score indicates TSLA does not meet the 80% threshold for 'some interest' or 90% for 'strong interest' according to this specific growth strategy.

Analysis

According to Validea's fundamental report, Tesla (TSLA) scores a 68% using the Motley Fool Small-Cap Growth Investor model, placing it below the 80% threshold that typically indicates strategic interest. This mixed assessment, reflected in a slightly negative sentiment score of -0.1, stems from a clear divergence between the company's financial health and its growth metrics. On one hand, Tesla passes several crucial fundamental tests, demonstrating solid profit margins, positive cash flow from operations, strong insider holdings, and a healthy long-term debt-to-equity ratio. On the other hand, the company fails on key criteria central to a growth-focused strategy, including relative strength, year-over-year sales and EPS growth, and the "Fool Ratio" (P/E to growth), suggesting that its current growth rate does not support its valuation. The report also flags failures related to average shares outstanding and sales, pointing towards potential shareholder dilution and a deceleration in top-line expansion that contradicts the typical profile of a high-growth stock.

Key Decisions for Investors

• Given the failure on key growth metrics like relative strength and year-over-year sales/EPS growth, investors with a short-to-medium term growth mandate should re-evaluate their position, as the stock does not meet the criteria of this specific growth model.
• The strong performance on fundamental metrics, such as profit margin and debt-to-equity, may appeal to long-term investors who prioritize balance sheet health over immediate growth momentum.
• Investors should closely monitor upcoming earnings reports for a potential re-acceleration in sales and EPS growth, as an improvement in these areas would be critical to justifying the company's valuation and refuting the negative signals highlighted in this analysis.
• The failure on the 'Fool Ratio' suggests the stock is overvalued on a price-to-earnings-to-growth basis, warranting a valuation discipline check for current and prospective shareholders.